What's Going On With Aptevo Therapeutics Shares Friday?

Comments
Loading...
Zinger Key Points

Aptevo Therapeutics, Inc. APVO stock is trading lower Friday after the company announced a 1-for-37 reverse stock split.

The Details: The goal of the reverse stock split is to regain compliance with minimum bid price requirement of $1.00 per share required to maintain continued listing on the Nasdaq.

Shares will begin trading on a split-adjusted basis on December 4 at market open. The reverse stock split will reduce the number of shares of the company’s outstanding common stock from approximately 18.5 million shares to 0.5 million shares.

It was approved by Aptevo’s shareholders at a special meeting held on Oct. 25, 2024.

How To Buy Aptevo Shares

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Aptevo Therapeutics's case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

APVO Price Action: At the time of writing Aptevo shares are trading 18.9% lower at 28 cents, according to data from Benzinga Pro.

Image: 6368031 from Pixabay.

APVO Logo
APVOAptevo Therapeutics Inc
$0.99010.96%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
1.11
Price Trend
Short
Medium
Long
Got Questions? Ask
Which healthcare ETFs might benefit from Aptevo?
How will investor sentiment shift after the split?
What other biotech stocks may follow suit with splits?
Which healthcare sector stocks are undervalued now?
How could reverse splits impact investor strategies?
What trends in biotech could affect future investments?
Who stands to gain from Aptevo's compliance efforts?
Could large-cap healthcare companies see increased interest?
What effect does NASDAQ listing have on investor behavior?
How might competitive pressures affect Aptevo's market position?
Market News and Data brought to you by Benzinga APIs

Posted In: